112 related articles for article (PubMed ID: 1683340)
1. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
Saletu B; Grünberger J; Anderer P; Chwatal K
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340
[TBL] [Abstract][Full Text] [Related]
2. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L; Anderer P
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
[TBL] [Abstract][Full Text] [Related]
4. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
[TBL] [Abstract][Full Text] [Related]
5. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
6. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
Saletu B; Grünberger L; Linzmayer L; Wittek R; Stöhr H
Wien Klin Wochenschr; 1983 Jul; 95(14):481-93. PubMed ID: 6356628
[TBL] [Abstract][Full Text] [Related]
7. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
[TBL] [Abstract][Full Text] [Related]
8. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
[TBL] [Abstract][Full Text] [Related]
9. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
Saletu B; Grünberger J; Linzmayer L; Dubini A
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
[TBL] [Abstract][Full Text] [Related]
10. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
11. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
Saletu B; Grünberger J; Anderer P; Linzmayer L
Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
[TBL] [Abstract][Full Text] [Related]
13. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
[TBL] [Abstract][Full Text] [Related]
14. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
Saletu B; Grünberger J
Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
[TBL] [Abstract][Full Text] [Related]
15. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
Saletu B; Grünberger J
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
[TBL] [Abstract][Full Text] [Related]
16. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study.
Meyer-Lindenberg A; Gruppe H; Bauer U; Lis S; Krieger S; Gallhofer B
Pharmacopsychiatry; 1997 Mar; 30(2):35-42. PubMed ID: 9131723
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):362-73. PubMed ID: 3525428
[TBL] [Abstract][Full Text] [Related]
18. Pharmaco-EEG studies with fluperlapine.
Matejcek M; Neff G; Tjeerdsma H; Krebs E
Arzneimittelforschung; 1984; 34(1A):114-20. PubMed ID: 6145426
[TBL] [Abstract][Full Text] [Related]
19. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam.
Kurowski M; Ott H; Herrmann WM
Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
